Jang Won Heo: Clinical Trials

1 trial sponsored by Jang Won Heo, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow Jang Won Heo: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ranibizumab Versus Low-fluence Photodynamic Therapy in the Treatment of Chronic Central Serous Chorioretinopathy
Verteporfin, ranibizumab - Chronic Central Serous Chorioretinopathy
Phase 1 / Phase 2CompletedJang Won Heo342009-07-012013-05-27

Interventions

Ranibizumab (1)  ·  Verteporfin (1)

Countries

South Korea (1)

Results publications

PMID 21742303, PMID 40522203